Previous Nav
Net Change on 15-07-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
SUN PHARMACEUTICAL INDUSTRIES LTD.
CASH / NET CURRENT ASSET
APOLLO HOSPITALS ENTERPRISE LTD.
CIPLA LTD.
DIVI LABORATORIES LTD.
AUROBINDO PHARMA LTD.
FORTIS HEALTHCARE LTD.
LUPIN LTD.
ASTER DM HEALTHCARE LTD.
WOCKHARDT LTD.
ALKEM LABORATORIES LTD.
HEALTHCARE GLOBAL ENTERPRISES LTD.
METROPOLIS HEALTHCARE LTD.
DR REDDYS LABORATORIES LTD.
DR. LAL PATH LABS LTD.
AJANTA PHARMA LTD.
TORRENT PHARMACEUTICALS LTD.
FDC LTD.
MEDI ASSIST HEALTHCARE SERVICES LTD.
KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.
INDOCO REMEDIES LTD.
IPCA LABORATORIES LTD.
DR. AGARWALS HEALTH CARE LTD.
JUPITER LIFE LINE HOSPITALS LTD.
AKUMS DRUGS AND PHARMACEUTICALS LTD
COROMANDEL INTERNATIONAL LTD.
ZYDUS LIFESCIENCES LTD.
NIVA BUPA HEALTH INSURANCE COMPANY LTD.
SANOFI INDIA LTD.
ACUTAAS CHEMICALS LTD.
SANOFI CONSUMER HEALTHCARE INDIA LTD.
MEDPLUS HEALTH SERVICES LTD.
MANKIND PHARMA LTD
PROCTER & GAMBLE HEALTH LTD.
GLAXOSMITHKLINE PHARMACEUTICALS LTD.
ORCHID PHARMA LTD.
SYNGENE INTERNATIONAL LTD.
INVENTURUS KNOWLEDGE SOLUTIONS LTD.
A) REPO
DEEPAK NITRITE LTD.
LAXMI DENTAL LIMITED
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Business Support
Fertilizers
Insurance
BPO/ITeS
Chemicals
Medical Equipment/Supplies/Accessories
Cash
Equity
Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹1,281.99 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.
The NAV of Tata India Pharma & Healthcare Fund ended up ₹0.39(1.28%)yesterday to ₹30.847.
Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and
The Tata India Pharma & Healthcare Fund is managed by Rajat Srivastava .
1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051